HighTower Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$696K Sell
18,083
-476
-3% -$19.6K ﹤0.01% 2447
2025
Q4
$763K Sell
18,559
-2,887
-13% -$114K ﹤0.01% 2310
2025
Q3
$798K Sell
21,446
-1,031
-5% -$37.5K ﹤0.01% 2266
2025
Q2
$820K Sell
22,477
-3,508
-14% -$127K ﹤0.01% 2145
2025
Q1
$1M Sell
25,985
-544
-2% -$21.6K ﹤0.01% 1959
2024
Q4
$1.01M Sell
26,529
-3,750
-12% -$150K ﹤0.01% 1965
2024
Q3
$1.27M Sell
30,279
-1,973
-6% -$81.9K ﹤0.01% 1779
2024
Q2
$1.31M Sell
32,252
-1,084
-3% -$43.1K ﹤0.01% 1704
2024
Q1
$1.38M Sell
33,336
-434
-1% -$18.2K ﹤0.01% 1622
2023
Q4
$1.36M Sell
33,770
-3,628
-10% -$139K ﹤0.01% 1674
2023
Q3
$1.47M Sell
37,398
-711
-2% -$28.3K ﹤0.01% 1554
2023
Q2
$1.54M Sell
38,109
-380
-1% -$15.6K ﹤0.01% 1504
2023
Q1
$1.61M Buy
38,489
+216
+0.6% +$9.09K ﹤0.01% 1417
2022
Q4
$1.67M Sell
38,273
-3,013
-7% -$128K ﹤0.01% 1382
2022
Q3
$1.61M Buy
41,286
+3,128
+8% +$133K ﹤0.01% 1359
2022
Q2
$1.61M Buy
38,158
+2,573
+7% +$112K ﹤0.01% 1371
2022
Q1
$1.63M Sell
35,585
-1,066
-3% -$47.2K ﹤0.01% 1491
2021
Q4
$1.78M Sell
36,651
-134
-0.4% -$6.34K ﹤0.01% 1428
2021
Q3
$1.76M Buy
36,785
+218
+0.6% +$10.6K ﹤0.01% 1330
2021
Q2
$1.78M Buy
36,567
+2,439
+7% +$117K 0.01% 1289
2021
Q1
$1.58M Sell
34,128
-630
-2% -$29.9K 0.01% 1264
2020
Q4
$1.66M Sell
34,758
-882
-2% -$40K 0.01% 992
2020
Q3
$1.53M Buy
35,640
+67
+0.2% +$2.87K 0.01% 1005
2020
Q2
$1.44M Buy
35,573
+7,618
+27% +$307K 0.01% 944
2020
Q1
$1.01M Sell
27,955
-5,551
-17% -$221K 0.01% 1006
2019
Q4
$1.43M Buy
33,506
+1,413
+4% +$56K 0.01% 974
2019
Q3
$1.22M Buy
32,093
+2,165
+7% +$83.3K 0.01% 1081
2019
Q2
$1.17M Sell
29,928
-2,580
-8% -$98.1K 0.01% 1118
2019
Q1
$1.29M Buy
32,508
+3,283
+11% +$130K 0.01% 1027
2018
Q4
$1.07M Sell
29,225
-421
-1% -$16.5K 0.01% 1012
2018
Q3
$1.26M Buy
29,646
+1,271
+4% +$51.5K 0.01% 1026
2018
Q2
$1.1M Buy
28,375
+688
+2% +$24.9K 0.01% 1076
2018
Q1
$971K Buy
27,687
+17,164
+163% +$611K 0.01% 1088
2017
Q4
$383K Sell
10,523
-3,867
-27% -$140K ﹤0.01% 1572
2017
Q3
$522K Buy
14,390
+2,025
+16% +$73.7K ﹤0.01% 1414
2017
Q2
$452K Buy
+12,365
New +$433K ﹤0.01% 1415

Other funds holding BME

HighTower Advisors's BME Position: Q1 2026 in Review

HighTower Advisors reduced its BlackRock Health Sciences Trust (BME) stake by 2.6% in Q1 2026, selling an estimated $19.6K and leaving 18,083 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

HighTower Advisors first reported a position in BME in Q2 2017 and has held it in 36 quarters since. The position peaked at $1.78M in Q4 2021. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • HighTower Advisors held 18,083 shares of BlackRock Health Sciences Trust worth $696K as of Q1 2026.
  • HighTower Advisors sold 476 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $19.6K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2447 holding.
  • HighTower Advisors first reported a position in BlackRock Health Sciences Trust in Q2 2017 and has held it in 36 quarters since.
  • HighTower Advisors's BlackRock Health Sciences Trust position peaked at $1.78M in Q4 2021.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.